For a deeper look at that philosophy, our Supplement Guide is a helpful next step
GLP-1 medications are often well suited for patients who: Experience frequent hunger or difficulty with portion control Respond well to appetite suppression alone Prefer a slower, more gradual weight loss trajectory Are sensitive to medications and benefit from a single-pathway approach While GLP-1 therapies can be highly effective, they may be less impactful for patients with significant insulin resistance or deeper metabolic dysfunction
This detailed comparison analyzes both blends point by point: composition, mechanisms of action, respective applications, and selection criteria
Semaglutide works by mimicking the GLP-1 hormone, which regulates blood sugar, slows gastric emptying, and enhances feelings of fullness
Semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) may reduce birth control effectiveness and may increase risk of birth defects if taken during pregnancy
Understanding what to expect during treatment helps you distinguish between normal adjustment symptoms and genuine warning signs